Media

Support Of Industry Underscores Pro-Business Commitment
Commercialization of cleaner, safer consumer products through innovative industrial biotechnology processes will be the focus of breakout sessions at the...

Press Releases

Jan 27 2014
Washington, D.C. (January 27, 2014) – The Biotechnology Industry Organization (BIO) announces registration for the newly improved 2014 BIO...
Jan 23 2014
The Biotechnology Industry Organization (BIO) thanks Sens. Dick Durbin (D-Ill.), Charles Grassley (R-Iowa), Al Franken (D-Minn.), and John Thune (R-S.D.) and...
Jan 23 2014
WASHINGTON, D.C. (January 23, 2014) – The Biotechnology Industry Organization (BIO) today announces plenary sessions, Business Roundtables...
Jan 22 2014
Washington, D.C. (January 22, 2014) – The Biotechnology Industry Organization (BIO) and the Washington Biotechnology & Biomedical Association (WBBA...
Jan 14 2014
Washington, D.C. (January 14, 2014) – The Biotechnology Industry Organization (BIO) today applauds House and Senate appropriators for reaching...
Jan 13 2014
Washington, DC (Monday, January 13, 2014) – Today, the Biotechnology Industry Organization (BIO) expresses strong support for the “Bipartisan...
Jan 9 2014
Washington, D.C. (January 9, 2014) – Today, Nature Biotechnology published a peer-reviewed paper co-authored by the Biotechnology Industry Organization...
Jan 7 2014
The Biotechnology Industry Organization (BIO) today echoed the request by the Secretaries of Energy, Agriculture and the Navy for funding and transfer...
Dec 19 2013
WASHINGTON, D.C. (December  19, 2013) - The Biotechnology Industry Organization (BIO) today announced the preliminary list of presenting companies for...


Biotechnology News

September 22, 2014

OSLO, Norway--(BUSINESS WIRE)--Reference is made to the announcement published on 16 September 2014 in which Nordic Nanovector AS (the “Company”) announced the final...

September 22, 2014

PARIS--(BUSINESS WIRE)--NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of...

September 20, 2014

MONT-TREMBLANT, Quebec--(BUSINESS WIRE)--FibroGen, Inc. (FibroGen) announced today the presentation of the full data set from a clinical study of patients with idiopathic...

September 19, 2014

LOS ANGELES--(BUSINESS WIRE)--Contact Glancy Binkow & Goldberg LLP if you purchased PDL BioPharma, Inc. securities between November 6, 2013 and September 16, 2014.